中文 | English
Return
Total: 2 , 1/1
Show Home Prev Next End page: GO
Author:(Kongjun LIU)

1.CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury.

Yong CHEN ; Xue YUAN ; Wei YAN ; Yurong ZOU ; Haoche WEI ; Yuhan WEI ; Minghai TANG ; Yulian CHEN ; Ziyan MA ; Tao YANG ; Kongjun LIU ; Baojian XIONG ; Xiuying HU ; Jianhong YANG ; Lijuan CHEN

Acta Pharmaceutica Sinica B 2025;15(7):3708-3724

2.Health management models of type 2 diabetes mellitus in domestic and foreign urban communities

Guozhi LIU ; Kongjun YUAN ; Wei ZHUANG ; Guangqing ZHOU

Journal of Preventive Medicine 2023;35(3):262-266

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 2 , 1/1 Show Home Prev Next End page: GO